These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32848877)

  • 1. Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation.
    Wang Q; Wang Z; Xu M; Tu W; Hsin IF; Stotland A; Kim JH; Liu P; Naiki M; Gottlieb RA; Seki E
    Front Physiol; 2020; 11():950. PubMed ID: 32848877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotropin suppresses inflammatory cytokine expression and cell death through suppression of NF-κB and JNK in hepatocytes.
    Zhang B; Roh YS; Liang S; Liu C; Naiki M; Masuda K; Seki E
    PLoS One; 2014; 9(12):e114071. PubMed ID: 25470242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patulin alleviates hepatic lipid accumulation by regulating lipogenesis and mitochondrial respiration.
    Yu S; Song JH; Kim HS; Hong S; Park SK; Park SH; Lee J; Chae YC; Park JH; Lee YG
    Life Sci; 2023 Aug; 326():121816. PubMed ID: 37271452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X; Liu Z; Wang J
    Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside ameliorates NAFLD via attenuating hepatic steatosis through inhibiting mitochondrial dysfunction dependent on SIRT5.
    Zhang S; Wu Z; Shi L; Yan S; Huang Z; Lu B; Wang Z; Ji L
    Phytomedicine; 2022 May; 99():153994. PubMed ID: 35220131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of metformin against palmitate-induced hepatic cell death.
    Geng Y; Hernández Villanueva A; Oun A; Buist-Homan M; Blokzijl H; Faber KN; Dolga A; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165621. PubMed ID: 31786336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress.
    Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH; Jung TW
    Biochem Pharmacol; 2022 May; 199():115022. PubMed ID: 35358477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.
    Wang Y; Chen C; Chen J; Sang T; Peng H; Lin X; Zhao Q; Chen S; Eling T; Wang X
    Redox Biol; 2022 Jun; 52():102322. PubMed ID: 35504134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling.
    Pyun DH; Kim TJ; Kim MJ; Hong SA; Abd El-Aty AM; Jeong JH; Jung TW
    J Cell Physiol; 2021 Jul; 236(7):4902-4912. PubMed ID: 33283879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
    Zhang J; Zhang W; Yang L; Zhao W; Liu Z; Wang E; Wang J
    Phytomedicine; 2023 Jan; 109():154589. PubMed ID: 36610145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
    Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
    Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.
    Dong J; Li M; Peng R; Zhang Y; Qiao Z; Sun N
    J Transl Med; 2024 Feb; 22(1):196. PubMed ID: 38395901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation.
    Zhou B; Zhou DL; Wei XH; Zhong RY; Xu J; Sun L
    Acta Pharmacol Sin; 2017 Jul; 38(7):998-1008. PubMed ID: 28344322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD
    Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB
    Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
    Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
    Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
    Li Y; Liu Y; Chen Z; Tang K; Yang L; Jiang Y; Wang J; Huang P; Wang J; Zheng P; Song H
    Biomed Pharmacother; 2023 Apr; 160():114319. PubMed ID: 36724639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin Attenuates Hepatic Steatosis by Enhancing Beta Oxidation and Energy Expenditure via AMPK Activation.
    Gwon SY; Ahn J; Jung CH; Moon B; Ha TY
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.